Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $304.96 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $145.19 | 1 | $0 (2022) |
| TEI Medical Inc. | $145.06 | 1 | $0 (2019) |
| Orexigen Therapeutics, Inc. | $14.71 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $145.19 | 1 | Gilead Sciences, Inc. ($145.19) |
| 2019 | $145.06 | 1 | TEI Medical Inc. ($145.06) |
| 2017 | $14.71 | 1 | Orexigen Therapeutics, Inc. ($14.71) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $145.19 | General |
| 05/14/2019 | TEI Medical Inc. | AMNIOEXCEL (Device), PRIMATRIX | Food and Beverage | In-kind items and services | $145.06 | General |
| Category: RECON-SKIN AND WOUND | ||||||
| 08/20/2017 | Orexigen Therapeutics, Inc. | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: OBESITY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 246 | 356 | $177,166 | $43,651 |
| 2022 | 6 | 318 | 452 | $239,810 | $57,025 |
| 2021 | 5 | 283 | 415 | $255,286 | $55,700 |
| 2020 | 4 | 300 | 424 | $208,789 | $55,928 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 89 | 187 | $69,041 | $20,092 | 29.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 111 | 115 | $87,055 | $18,392 | 21.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 21 | 22 | $9,636 | $2,319 | 24.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 21 | $5,670 | $1,532 | 27.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $5,764 | $1,315 | 22.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 138 | 145 | $100,459 | $25,955 | 25.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 103 | 226 | $83,168 | $21,007 | 25.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 22 | 24 | $18,170 | $3,266 | 18.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 18 | 18 | $18,072 | $3,044 | 16.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 25 | 26 | $10,653 | $2,576 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 12 | 13 | $9,288 | $1,177 | 12.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 119 | 128 | $84,265 | $23,249 | 27.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 89 | 191 | $70,267 | $18,128 | 25.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 22 | 42 | $77,826 | $8,371 | 10.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 31 | 32 | $12,896 | $3,202 | 24.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 22 | 22 | $10,032 | $2,750 | 27.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 142 | 146 | $96,068 | $27,964 | 29.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 112 | 230 | $84,640 | $22,063 | 26.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 33 | 35 | $14,105 | $3,627 | 25.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 13 | 13 | $13,976 | $2,275 | 16.3% |
About Dr. Brian Scott, MD
Dr. Brian Scott, MD is a Neurocritical Care healthcare provider based in Stanford, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1356475222.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Scott, MD has received a total of $304.96 in payments from pharmaceutical and medical device companies, with $145.19 received in 2022. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($304.96).
As a Medicare-enrolled provider, Scott has provided services to 1,147 Medicare beneficiaries, totaling 1,647 services with total Medicare billing of $212,303. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Neurocritical Care
- Other Specialties Neurology
- Location Stanford, CA
- Active Since 03/15/2007
- Last Updated 11/13/2023
- Taxonomy Code 2084A2900X
- Entity Type Individual
- NPI Number 1356475222
Products in Payments
- AMNIOEXCEL (Device) $145.06
- CONTRAVE (Drug) $14.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.